Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa

Phase: N/A Priority: Normal
NCT ID: NCT05111600 Org: User:
Start: 07/15/22 End: 11/22/24 Due: 11/22/25

Clinical Trial to Assess the Safety and Efficacy of Investigational Product in Patients Due to Hypospadias Treatment Failure

Phase: N/A Priority: Normal
NCT ID: NCT05093166 Org: User:
Start: 11/26/21 End: 12/12/22 Due: 12/12/23

Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT02577861 Org: User:
Start: 10/31/15 End: 03/11/22 Due: 03/11/23

Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With JEB (HOLOGENE17)

Phase: N/A Priority: Normal
NCT ID: NCT03490331 Org: User:
Start: 03/19/18 End: 09/11/18 Due: 09/11/19

Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns

Phase: N/A Priority: Normal
NCT ID: NCT03288844 Org: User:
Start: 12/13/17 End: 03/31/23 Due: 03/31/24

Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB.

Phase: N/A Priority: Normal
NCT ID: NCT02984085 Org: User:
Start: 01/30/17 End: 08/06/18 Due: 08/06/19